标普生物科技LOF(161127)
动态评分： 6.09分
投资组合
| 报告日期 | 代码 | 名称 | 类型 | 金额(万元) | 占期初比 |
| 2020-12-31 | REGN | 再生元制药 | 买入 | 82.62 | 1.09% |
| 2020-12-31 | BCRX | BioCryst Pharmaceuticals Inc | 买入 | 81.36 | 1.07% |
| 2020-12-31 | BMRN | 拜玛林制药 | 买入 | 79.75 | 1.05% |
| 2020-12-31 | SRNE | Sorrento Therapeutics Inc | 买入 | 80.16 | 1.05% |
| 2020-12-31 | GILD | 吉利德科学 | 买入 | 77.24 | 1.02% |
| 2020-12-31 | MRNA | Moderna Inc | 买入 | 76.7 | 1.01% |
| 2020-12-31 | MCRB | Seres Therapeutics Inc | 买入 | 75.91 | 1% |
| 2020-06-30 | NVAX | 诺瓦瓦克斯医药 | 买入 | 139.59 | 1.84% |
| 2020-06-30 | INO | Inovio Pharmaceuticals Inc | 买入 | 107.68 | 1.42% |
| 2020-06-30 | BBIO | BridgeBio Pharma Inc | 买入 | 88.79 | 1.17% |
| 2020-06-30 | KRTX | Karuna Therapeutics Inc | 买入 | 77.86 | 1.02% |
| 2020-06-30 | BTAI | BioXcel Therapeutics Inc | 买入 | 75.53 | 0.99% |
| 2020-06-30 | BCRX | BioCryst Pharmaceuticals Inc | 买入 | 71.3 | 0.94% |
| 2020-06-30 | MRNA | Moderna Inc | 买入 | 70.46 | 0.93% |
| 2020-06-30 | CCXI | ChemoCentryx Inc | 买入 | 68.06 | 0.9% |
| 2020-06-30 | CLVS | Clovis Oncology Inc | 买入 | 68.5 | 0.9% |
| 2020-06-30 | MNTA | Momenta Pharmaceuticals Inc | 买入 | 67.38 | 0.89% |
| 2020-06-30 | ESPR | Esperion Therapeutics Inc | 买入 | 61.36 | 0.81% |
| 2020-06-30 | SRNE | Sorrento Therapeutics Inc | 买入 | 59.7 | 0.79% |
| 2020-06-30 | AIMT | Aimmune Therapeutics Inc | 买入 | 59.23 | 0.78% |
公告&资料
